readthroughSign in
CompanyAMRXNasdaq

Amneal Pharmaceuticals, LLC

Amneal Pharmaceuticals develops approximately 300 complex generic, specialty, and biosimilar medicines across neurology, endocrinology, and other therapeutic areas.

DEF 14ASep 18Latest SEC filing, period to Sep 18
Sep 14Latest story

September 2026

August 2026

July 2026